Divergent with the main topic of this review, metformin decreased miR-34a but exhibited anti-EMT effects; thus, metformin may bidirectionally regulate the (SNAIL/miR-34):(ZEB/miR-200) system for CRC therapy. This evidence concerns the gene SNAI1 and colorectal carcinoma.